1Anesthesia, Intensive Care and Pain Therapy, University of Pavia, Pavia, Italy. 2Anesthesia and Intensive Care, Emergency Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. 3Royal Brompton Hospital Cardiology Unit NHS Foundation Trust, London, United Kingdom. 4IRCCS "S.Maria Nascente", Don Gnocchi Foundation, Milan, Italy. 5Royal Brompton Hospital NHS Foundation Trust, Adult Intensive Care, London, United Kingdom.
Crit Care Med. 2016 Aug;44(8):e755-61. doi: 10.1097/CCM.0000000000001655.
Inotropic and vasopressor drugs are routinely used in critically ill patients to maintain adequate blood pressure and cardiac output in patients with cardiogenic shock although potentially at the expense of increasing myocardial oxygen demand. Pacing optimization has been demonstrated as effective in reducing catecholamine requirements in patients with chronic heart failure by improving cardiac efficiency; however, there are no reports relating to the effectiveness of pacemaker optimization on cardiac output in critically ill patients with cardiogenic shock in the intensive care.
Retrospective data analysis.
Twenty-bed adult tertiary cardiothoracic ICU, university hospital.
Eight sequential patients receiving dual chamber pacemaker with DDD modality with cardiogenic shock and hemodynamic instability refractory to catecholamines underwent echocardiography-guided pacemaker optimization of cardiac output. An iterative method with Doppler echocardiography was used to assess changes in cardiac output, left ventricular filling time, ejection time, total isovolumic time, mitral regurgitation, ejection fraction, and blood pressure at different increments of heart rate, and atrioventricular and interventricular delay. All results are shown as median (minimum/maximum level) or mean ± SD.
Using echocardiography-guided pacemaker optimization on cardiac output, the cardiac output increased from 3.2 (2.3/3.8) to 5.7 L/min (4.85/7.1) and cardiac index from 1.64 (1.1/1.9) to 2.68 L/min/m (2.1/3.2) and the total isovolumic time reduced from 22.8 to normal values (<14). In association, the glomerular filtration rate increased significantly except in one patient with stage IV chronic kidney disease. All inotropes and vasopressors were discontinued within 12 hours of pacemaker optimization on cardiac output, and all patients were discharged from the ICU within 1 week.
Echocardiography-guided pacemaker optimization of cardiac output is a feasible bedside therapeutic option, which should be considered when standard medical treatments are insufficient for the treatment of cardiogenic shock refractory to inotropic support, thereby minimizing the detrimental effect of catecholamines.
在患有心源性休克的危重病患者中,通常会使用正性肌力和血管加压药物来维持足够的血压和心输出量,尽管这可能会增加心肌氧需求。起搏优化已被证明通过提高心脏效率在慢性心力衰竭患者中有效降低儿茶酚胺需求;然而,在重症监护中,没有关于起搏优化对心源性休克危重病患者心输出量的有效性的报告。
回顾性数据分析。
大学医院 20 张成人心胸科 ICU 病床。
8 例连续心源性休克和儿茶酚胺抵抗性血流动力学不稳定的双腔起搏器患者接受了以 DDD 模式的双腔起搏器,并进行了超声心动图引导下的心脏输出量起搏优化。使用多普勒超声心动图的迭代方法来评估不同心率增加、房室和室间隔延迟时心输出量、左心室充盈时间、射血时间、总等容时间、二尖瓣反流、射血分数和血压的变化。所有结果均以中位数(最小值/最大值)或平均值±SD 表示。
使用超声心动图引导的心脏输出量起搏优化,心输出量从 3.2(2.3/3.8)增加到 5.7 L/min(4.85/7.1),心指数从 1.64(1.1/1.9)增加到 2.68 L/min/m(2.1/3.2),总等容时间缩短至正常范围(<14)。同时,除了 1 例慢性肾脏病 4 期患者外,肾小球滤过率均显著增加。所有正性肌力和血管加压药物均在心脏输出量起搏优化后 12 小时内停用,所有患者均在 1 周内从 ICU 出院。
超声心动图引导的心脏输出量起搏优化是一种可行的床边治疗选择,当标准药物治疗不足以治疗对正性肌力支持有抵抗的心源性休克时,应考虑使用该方法,从而最小化儿茶酚胺的有害影响。